Replies to post #130381 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

he states that there will be a suite of 10 drug guidances for unmet disease needs, five of them neurological, before the end of the year...Gottlieb...

.

Just curious. We have filled in some AVXL blanks here and see Rett, PD and AD trials included in the 5 new CNS referenced by FDA as starters in CY 2017. Anyone else aware of other thoughts, claims, plans being discussed among boards? AVXL not the only game in town.

Other non CNS trials? Seems different that such potential would be so low key.